Company Research Report: FidoCure by One Health Company

Company Overview

Name and Mission of the Company

Name: FidoCure by One Health Company

Mission: To eradicate canine cancer, improve the quality of life for canine patients, and give new hope to pet parents.

Founding Details

Founded By: Christina Lopes and Ben Lewis

Founding Story: The company was built on personal experiences with cancer. Ben Lewis, involved with clinical trials, and Christina Lopes, having cared for cancer patients, sought to create a platform bridging innovative treatments for canine cancer.

Key People

Christina Lopes: Co-Founder & CEO

Benjamin Lewis: Co-Founder

Dr. Gerald Post: Chief Medical Officer

Ben Toussant: Vice President, Operations

Chase Schwalbach: Chief Product Officer

Headquarters

No information is available

Number of Employees

No information is available

Revenue

No information is available

Known For

FidoCure is recognized for using genomic testing to provide precision medicine solutions for canine cancer care, offering advanced diagnostic services and targeted therapies.

Products

Products Offered

FidoCure Platform: Offers AI-driven precision medicine for canine cancer.

Product Descriptions & Key Features

FidoCure Precision Medicine Platform

Description: Uses genomic testing to personalize cancer treatment for dogs.

Key Features:

DNA Sequencing: Provides personalized DNA reports that identify genetic mutations affecting treatment options.

Targeted Therapy: Recommends therapies based on genomic signatures, allowing for precise attack on cancer cells.

AI-Driven Approach: Combines AI with veterinary knowledge to optimize cancer care for dogs.

Recent Developments

Recent Company Developments

Patent Acquisition: Received a patent for AI-driven drug development.

Genomic Studies Published:

April 28, 2023: Analysis of canine cancer mutations using real-world data.

July 6, 2023: Research on shared hotspot mutations in oncogenes indicating dogs as models for precision therapeutics.

September 21, 2023: Study on hemangiosarcoma with insights from genetic data.

New Products Launched

No information is available

New Features Added

No information is available

New Partnerships

Collaboration with Researchers: Engaged with institutions like Tufts University and Broad Institute for research on canine and comparative oncology.

Analysis

Data Reach: Developed the largest in vivo spontaneous cancer dataset, aiding drug development and translational research.

Conclusion

FidoCure by One Health Company is pioneering the integration of precision medicine into veterinary oncology, with a focus on improving outcomes for canine cancer patients. The company's use of genomic data and AI reflects a commitment to innovation and efficacy in canine cancer treatments.